[go: up one dir, main page]

HU9402925D0 - Vew use of beta-carbolines - Google Patents

Vew use of beta-carbolines

Info

Publication number
HU9402925D0
HU9402925D0 HU9402925A HU9402925A HU9402925D0 HU 9402925 D0 HU9402925 D0 HU 9402925D0 HU 9402925 A HU9402925 A HU 9402925A HU 9402925 A HU9402925 A HU 9402925A HU 9402925 D0 HU9402925 D0 HU 9402925D0
Authority
HU
Hungary
Prior art keywords
vew
carbolines
beta
vew use
Prior art date
Application number
HU9402925A
Other languages
Hungarian (hu)
Other versions
HUT68212A (en
Inventor
Peter Andreas Loeschmann
David Norman Stephens
Andreas Huth
Martin Krueger
Dieter Rahtz
Dieter Seidelmann
Herbert Schneider
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU9402925D0 publication Critical patent/HU9402925D0/en
Publication of HUT68212A publication Critical patent/HUT68212A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9402925A 1992-04-10 1993-04-06 Process for producing new beta-carbolines and pharmaceutical compositions which are applicable for treatment of neurological and psychiatric disorders and containing beta-carbolines HUT68212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4212529A DE4212529A1 (en) 1992-04-10 1992-04-10 Use of µ-carbolines as non-competitive glutamate antagonists

Publications (2)

Publication Number Publication Date
HU9402925D0 true HU9402925D0 (en) 1995-01-30
HUT68212A HUT68212A (en) 1995-06-28

Family

ID=6456829

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402925A HUT68212A (en) 1992-04-10 1993-04-06 Process for producing new beta-carbolines and pharmaceutical compositions which are applicable for treatment of neurological and psychiatric disorders and containing beta-carbolines

Country Status (10)

Country Link
EP (1) EP0633779A1 (en)
JP (1) JPH07505404A (en)
KR (1) KR950700739A (en)
CA (1) CA2117755A1 (en)
DE (1) DE4212529A1 (en)
FI (1) FI944714A0 (en)
HU (1) HUT68212A (en)
IL (1) IL105349A0 (en)
WO (1) WO1993020820A1 (en)
ZA (1) ZA932553B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330175A1 (en) * 1993-08-31 1995-03-02 Schering Ag Alkoxy substituted beta carbolines
DE4436190A1 (en) * 1994-10-10 1996-04-11 Gerhard Prof Dr Bringmann Halogenated β-carboline derivatives, process for their preparation and use of these substances for inhibiting the respiratory chain
RU2106864C1 (en) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров New approach to treatment of alzheimer's disease
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
PL332413A1 (en) 1996-09-27 1999-09-13 Guilford Pharm Inc Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals
WO2006133391A2 (en) * 2005-06-06 2006-12-14 Fibrogen, Inc. Improved treatment for anemia using a hif-alpha stabilising agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540653A1 (en) * 1985-11-13 1987-05-14 Schering Ag NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
DE3545776A1 (en) * 1985-12-20 1987-06-25 Schering Ag 5-AMINOALKYL-SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
DE4212529A1 (en) 1993-10-14
ZA932553B (en) 1993-11-02
JPH07505404A (en) 1995-06-15
EP0633779A1 (en) 1995-01-18
FI944714L (en) 1994-10-07
IL105349A0 (en) 1993-08-18
WO1993020820A1 (en) 1993-10-28
KR950700739A (en) 1995-02-20
CA2117755A1 (en) 1993-10-11
FI944714A0 (en) 1994-10-07
HUT68212A (en) 1995-06-28

Similar Documents

Publication Publication Date Title
AU117975S (en) Set of containers
HU9303601D0 (en) Imidazopyridine
AU115927S (en) Ring
AU118073S (en) Set of utensils
HU9302059D0 (en) Differentiating factor of megacaryocyte
IL103349A0 (en) Ring
HK1001330A1 (en) Purification of fluoropolymers
ZA942543B (en) Tetrohydro beta-carbolines
HU9402925D0 (en) Vew use of beta-carbolines
GB9305605D0 (en) Apparatus of accomplishing autoport selection
ZA932459B (en) Imidazopyridines
GB9222985D0 (en) Use of the tarchonanthus camphoratus
ZA937875B (en) Imidazopyridines
ZA934243B (en) Separation of unsaturates
EP0553954A3 (en) Preparation of tetramethyldiamino-polyoxyethylenes
ZA931368B (en) Sulphonylbenzyl-substituted imidazopyridines
GB9220894D0 (en) New use of the pyrazolopyridine compound
IL105369A0 (en) Process and intermediates for the preparation of 2-amino-5-methyl-pyridine
GB9215794D0 (en) New use of the pyrazolopyridine compound
GB9212264D0 (en) New use of the pyrazolopyridine compound
CA71834S (en) Set of containers
GB9203348D0 (en) New use of wf13533 substance
GB9223098D0 (en) Electro-analysis of liquids
GB9217628D0 (en) Use of rapamycin
GB9205486D0 (en) Spraying of liquids

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee